<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Bertheloot D</submitter><funding>Deutsche Forschungsgemeinschaft</funding><funding>European Research Council</funding><pagination>e15415</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9174887</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>14(6)</volume><pubmed_abstract>Inflammasomes sense intracellular clues of infection, damage, or metabolic imbalances. Activated inflammasome sensors polymerize the adaptor ASC into micron-sized "specks" to maximize caspase-1 activation and the maturation of IL-1 cytokines. Caspase-1 also drives pyroptosis, a lytic cell death characterized by leakage of intracellular content to the extracellular space. ASC specks are released among cytosolic content, and accumulate in tissues of patients with chronic inflammation. However, if extracellular ASC specks contribute to disease, or are merely inert remnants of cell death remains unknown. Here, we show that camelid-derived nanobodies against ASC (VHH&lt;sub>ASC&lt;/sub> ) target and disassemble post-pyroptotic inflammasomes, neutralizing their prionoid, and inflammatory functions. No</pubmed_abstract><journal>EMBO molecular medicine</journal><pubmed_title>Nanobodies dismantle post-pyroptotic ASC specks and counteract inflammation in vivo.</pubmed_title><pmcid>PMC9174887</pmcid><funding_grant_id>714175</funding_grant_id><funding_grant_id>TRR237‐369799452</funding_grant_id><funding_grant_id>EXC 2151‐390873048</funding_grant_id><funding_grant_id>PLAT‐IL‐1</funding_grant_id><funding_grant_id>322568668</funding_grant_id><pubmed_authors>Wuerth JD</pubmed_authors><pubmed_authors>Wanderley CW</pubmed_authors><pubmed_authors>Duthie F</pubmed_authors><pubmed_authors>Schneider AH</pubmed_authors><pubmed_authors>Bertheloot D</pubmed_authors><pubmed_authors>Tesfamariam YM</pubmed_authors><pubmed_authors>Schiffelers LD</pubmed_authors><pubmed_authors>Rosero N</pubmed_authors><pubmed_authors>Maasewerd S</pubmed_authors><pubmed_authors>Todtmann JM</pubmed_authors><pubmed_authors>Rohland C</pubmed_authors><pubmed_authors>Schmidt FI</pubmed_authors><pubmed_authors>Cunha FQ</pubmed_authors><pubmed_authors>Hawwari I</pubmed_authors><pubmed_authors>Ribeiro LS</pubmed_authors><pubmed_authors>Jenster LM</pubmed_authors><pubmed_authors>Franklin BS</pubmed_authors></additional><is_claimable>false</is_claimable><name>Nanobodies dismantle post-pyroptotic ASC specks and counteract inflammation in vivo.</name><description>Inflammasomes sense intracellular clues of infection, damage, or metabolic imbalances. Activated inflammasome sensors polymerize the adaptor ASC into micron-sized "specks" to maximize caspase-1 activation and the maturation of IL-1 cytokines. Caspase-1 also drives pyroptosis, a lytic cell death characterized by leakage of intracellular content to the extracellular space. ASC specks are released among cytosolic content, and accumulate in tissues of patients with chronic inflammation. However, if extracellular ASC specks contribute to disease, or are merely inert remnants of cell death remains unknown. Here, we show that camelid-derived nanobodies against ASC (VHH&lt;sub>ASC&lt;/sub> ) target and disassemble post-pyroptotic inflammasomes, neutralizing their prionoid, and inflammatory functions. No</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Jun</publication><modification>2025-04-19T17:36:41.612Z</modification><creation>2025-02-19T03:58:47.173Z</creation></dates><accession>S-EPMC9174887</accession><cross_references><pubmed>35438238</pubmed><doi>10.15252/emmm.202115415</doi></cross_references></HashMap>